Position in GYRE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$329
-$19 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 60 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GoalVest Advisory LLC holds $115,261 across 8 Biotechnology names. GYRE ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
2,100 | $50,568 | |
| 2 | RPRX |
Royalty Pharma plc
|
534 | $29,941 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
27 | $16,835 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
200 | $7,802 | |
| 5 | OTLK |
Outlook Therapeutics, Inc.
|
3,000 | $4,770 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
500 | $4,377 | |
| 7 | INSM |
INSMED Inc
|
6 | $639 | |
| 8 | GYRE |
Gyre Therapeutics, Inc.
This page
|
50 | $329 |
All Filings in GYRE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329 | 50 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $348 | 50 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||